{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:23:45Z","timestamp":1783027425418,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ekir.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:59:07Z","timestamp":1754927947000},"page":"3843-3854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Shiga Toxin\u2013Producing Escherichia coli\u2013Associated Hemolytic Uremic Syndrome in Adult Kidney Transplant Recipients"],"prefix":"10.1016","volume":"10","author":[{"given":"Manal","family":"Mazloum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tr\u00e9moli\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Baili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Prov\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Gamot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Westeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatouma","family":"Tour\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Anglicheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sberro-Soussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bonacorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Cointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Scemla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.08.004_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.ekir.2025.08.004_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12168","article-title":"Unveiling the incidence and graft survival rate in kidney transplant recipients with de novo thrombotic microangiopathy: a systematic review and meta-analysis","volume":"37","author":"Hsiung","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2025.08.004_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12882-023-03326-8","article-title":"Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology","volume":"24","author":"Von Tokarski","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human Shiga toxin\u2013producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.ekir.2025.08.004_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0042-108444","article-title":"Extrarenal manifestations in Shigatoxin-associated haemolytic uremic syndrome","volume":"228","author":"Matthies","year":"2016","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ekir.2025.08.004_bib11","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3201\/eid2707.204638","article-title":"Shiga toxin\u2013associated hemolytic uremic syndrome in adults, France, 2009\u20132017","volume":"27","author":"Dossier","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ekir.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/644621","article-title":"Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000\u20132006","volume":"49","author":"Gould","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ekir.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.ekir.2025.08.004_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/toxins13050306","article-title":"Shiga toxin-associated hemolytic uremic syndrome: specificities of adult patients and implications for critical care management","volume":"13","author":"Rafat","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.ekir.2025.08.004_bib16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.kint.2019.08.024","article-title":"Shiga toxin\u2013producing Escherichia coli\u2013associated hemolytic uremic syndrome in solid organ transplant recipients","volume":"96","author":"Ville","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.08.004_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/2175-8239-jbn-2020-0048","article-title":"Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report","volume":"43","author":"Nieto-Rios","year":"2021","journal-title":"Braz J Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib18","first-page":"1","article-title":"An atypical case of Shiga toxin producing- Escherichia coli hemolytic and uremic syndrome (STEC-HUS) in a lung transplant recipient","volume":"2019","author":"Mani\u00e8re","year":"2019","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.mayocpiqo.2018.07.001","article-title":"Hemolytic uremic syndrome associated with Escherichia coli O157 infection in an allogenic stem cell transplant recipient","volume":"2","author":"Vera-Aguilera","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ekir.2025.08.004_bib20","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2025.08.004_bib21","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.8.1800068","article-title":"Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016","volume":"24","author":"Bruyand","year":"2019","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ekir.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.08.004_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227445","article-title":"Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes","volume":"15","author":"Teixeira","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2025.08.004_bib24","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS)","volume":"34","author":"Khalid","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/jcm8070919","article-title":"Outcomes of kidney transplant patients with atypical hemolytic uremic syndrome treated with eculizumab: a systematic review and meta-analysis","volume":"8","author":"Gonzalez Suarez","year":"2019","journal-title":"JCM"},{"key":"10.1016\/j.ekir.2025.08.004_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00431-009-1079-9","article-title":"Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997\u20132003","volume":"169","author":"Schifferli","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ekir.2025.08.004_bib27","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of Shiga toxin hemolytic uremic syndrome","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajt.2024.01.029","article-title":"De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury","volume":"24","author":"Dessaix","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ckj\/sfx030","article-title":"Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential","volume":"10","author":"Dowen","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2025.08.004_bib30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","article-title":"Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations","volume":"13","author":"Alberti","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfw078","article-title":"Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli -associated paediatric haemolytic uraemic syndrome","volume":"31","author":"Ahlenstiel-Grunow","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ekir.2025.08.004_bib34","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ekir.2025.08.004_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2215\/CJN.05830518","article-title":"Complement gene variants and Shiga toxin\u2013producing Escherichia coli\u2013associated hemolytic uremic syndrome: retrospective genetic and clinical study","volume":"14","author":"Fr\u00e9meaux-Bacchi","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib36","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00431-018-3255-2","article-title":"Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study","volume":"177","author":"Karnisova","year":"2018","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ekir.2025.08.004_bib37","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.2024024976","article-title":"Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment","volume":"144","author":"Yousfi","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2025.08.004_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/toxins15010010","article-title":"Diagnosis and treatment for Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome","volume":"15","author":"Liu","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.ekir.2025.08.004_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2025.08.004_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-6143.2008.02482.x","article-title":"Belatacept as maintenance immunosuppression for postrenal Transplant de novo Drug-Induced thrombotic microangiopathy","volume":"9","author":"Ashman","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/260254","article-title":"Use of Belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy","volume":"2013","author":"Cicora","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1016\/j.ekir.2025.08.004_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/ctr.12170","article-title":"Successful conversion to Belatacept after thrombotic microangiopathy in kidney transplant patients","volume":"27","author":"Koppula","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib43","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.transproceed.2016.04.005","article-title":"Belatacept and eculizumab for treatment of calcineurin inhibitor-induced thrombotic microangiopathy after kidney transplantation: case report","volume":"48","author":"Merola","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2025.08.004_bib44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1097\/TP.0b013e3181a991ca","article-title":"Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation","volume":"87","author":"Midtvedt","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2025.08.004_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ckj\/sfx053","article-title":"Effective immunosuppressive management with Belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1\/CFHR3 and the presence of CFH antibodies","volume":"10","author":"M\u00fcnch","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2025.08.004_bib46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.transproceed.2016.11.008","article-title":"Eculizumab and Belatacept for de novo atypical hemolytic uremic syndrome associated with CFHR3-CFHR1 deletion in a kidney transplant recipient: a case report","volume":"49","author":"Dedhia","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2025.08.004_bib47","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic\u2013uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2025.08.004_bib48","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin\u2013associated HUS","volume":"364","author":"Anne-Laure","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.08.004_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00467-018-3903-9","article-title":"Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study","volume":"33","author":"Percheron","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2025.08.004_bib50","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1681\/ASN.0000000000000182","article-title":"Efficacy and safety of eculizumab in pediatric patients affected by Shiga toxin\u2013related hemolytic and uremic syndrome: a randomized, placebo-controlled trial","volume":"34","author":"Garnier","year":"2023","journal-title":"JASN"},{"key":"10.1016\/j.ekir.2025.08.004_bib51","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.46.11.3478-3483.2002","article-title":"Effects of azithromycin on Shiga toxin production by Escherichia coli and subsequent host inflammatory response","volume":"46","author":"Ohara","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ekir.2025.08.004_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058959","article-title":"Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice","volume":"8","author":"Amran","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2025.08.004_bib53","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/AAC.01783-09","article-title":"Different classes of antibiotics differentially influence Shiga toxin production","volume":"54","author":"McGannon","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925004966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925004966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:54:09Z","timestamp":1783025649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925004966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2468024925004966"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.08.004","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shiga Toxin\u2013Producing Escherichia coli\u2013Associated Hemolytic Uremic Syndrome in Adult Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}